Entera Bio Ltd.
Entera Bio Ltd. (ENTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENTX · as of Jun 8, 2026
Key Statistics
Explore Entera Bio Ltd. Data
entx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
entx competitorsENTX
ABOS
AGEN
ANIX
HURA
INOStock Performance
Full HistoryAbout Entera Bio Ltd.
Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that curr…
what is entera bio ltd. · entx stock overview · entera bio ltd. company profile · who is entera bio ltd. ceo · entx NASDAQ · entera bio ltd. headquarters · entera bio ltd. business segments
About Stock Overview & Key Data
Entera Bio Ltd. (ENTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 28, 2018. As of the latest trading session, ENTX stock price is $1.20, with a market capitalization of $59.1M. The stock has returned -43.40% over the past 12 months and -38.14% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Entera Bio Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Entera Bio Ltd. reported revenue of $42000.00 and net income of -$11.4M. For detailed data — including Entera Bio Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Entera Bio Ltd. (ENTX) stock price is $1.20. The stock is traded on NASDAQ under the ticker symbol ENTX. The 52-week range is $0.91 – $3.22.